Coronary artery bypass surgery in patients with impaired left ventricular function. Predictors of hospital outcome

M A Soliman Hamad1, K Peels, A Van Straten

  • 1Department of Cardio-Thoracic Surgery, Catharina Hospital Eindhoven, The Netherlands.

Insights

Coronary artery bypass grafting (CABG) is safe for patients with impaired left ventricular function, showing improved ejection fraction post-surgery. Preoperative thallium scans predict recovery, while ECG Q waves or high end-systolic volumes indicate poor outcomes.

Area of Science:

  • Cardiology
  • Cardiac Surgery
  • Cardiovascular Imaging

Background:

  • Patients with coronary artery disease and impaired left ventricular function (ejection fraction [EF] ≤ 40%) present a surgical challenge.
  • Coronary artery bypass grafting (CABG) outcomes in this population require careful evaluation.
  • Assessing myocardial viability and predicting surgical success are critical.

Purpose of the Study:

  • To evaluate the surgical outcome of CABG in patients with impaired left ventricular function.
  • To identify predictors of short-term and long-term outcomes following CABG in this cohort.
  • To assess the recovery of left ventricular function after CABG.

Main Methods:

  • Prospective study of 75 consecutive patients undergoing CABG with EF ≤ 40%.
  • Preoperative echocardiography and thallium-201 myocardial scintigraphy to assess left ventricular function and myocardial viability.
  • Postoperative echocardiography at discharge and six months for functional recovery assessment.

Main Results:

  • Low overall mortality (6.7%), with 4% cardiac-related deaths.
  • Significant improvement in left ventricular ejection fraction (EF) immediately post-CABG (32.2% to 39.5%) and sustained at follow-up (44.0%).
  • Extensive reversible defects on thallium scans predicted significant EF improvement; pathological Q waves or elevated LV end-systolic volume index (>100 ml/m²) predicted poor outcomes.

Conclusions:

  • CABG can be performed safely in patients with significant left ventricular dysfunction, demonstrating low mortality and morbidity.
  • Preoperative thallium-201 scintigraphy revealing extensive reversible defects is a strong predictor of myocardial function recovery.
  • Pathological Q waves on ECG or a left ventricular end-systolic volume index > 100 ml/m² suggest a higher risk of poor surgical outcomes.

Related Concept Videos

Cardiomyopathy VII: Pre and Post Operative Nursing Management01:28

Cardiomyopathy VII: Pre and Post Operative Nursing Management

Patients with hypertrophic cardiomyopathy (HCM) and left ventricular outflow tract (LVOT) obstruction who remain symptomatic despite optimal medical therapy may undergo a septal myectomy (Morrow procedure). This procedure involves excising a portion of the hypertrophied septum below the aortic valve using a heart-lung machine to improve blood flow through the LVOT. Effective preoperative and postoperative nursing management ensures successful patient outcomes, minimizes complications, and...
Cardiomyopathy V: Interprofessional Care01:29

Cardiomyopathy V: Interprofessional Care

Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...
Acute Coronary Syndrome III: Diagnostic Studies01:30

Acute Coronary Syndrome III: Diagnostic Studies

Diagnosing acute coronary syndrome or ACS begins with a thorough patient history. Notable symptoms include central, crushing chest pain radiating to the left arm, neck, jaw, or back, along with shortness of breath, sweating (diaphoresis), nausea, vomiting, dizziness, and palpitations.It is crucial to note any history of cardiac illnesses and assess risk factors, including age, gender, smoking, hypertension, diabetes, hyperlipidemia, and a sedentary lifestyle.During physical examination, vital...
Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
Imbalances in Cardiac Output01:26

Imbalances in Cardiac Output

The heart's primary function is to pump blood throughout the body, maintaining a balance between blood sent out (cardiac output) and blood returning (venous return). If this balance is disrupted, it can result in congestive heart failure (CHF), a severe condition where the heart becomes an inefficient pump, leading to inadequate blood circulation.
CHF can occur due to the failure of either side of the heart. Left-side failure leads to pulmonary congestion—the right side continues to send blood...
Coronary Artery Disease V: Interprofessional Care01:27

Coronary Artery Disease V: Interprofessional Care

Interprofessional care for coronary artery disease includes pharmacological therapy and revascularization procedures.Pharmacological therapy for Coronary Artery Disease (CAD) aims to manage symptoms, prevent complications, and improve patient outcomes through various classes of medications:Antiplatelet Agents:Aspirin and Clopidogrel: These medications inhibit platelet aggregation, preventing blood clots, which is crucial for avoiding heart attacks and strokes. Doctors often prescribe these...